Sorrento Therapeutics, Inc. Celularity Inc (CELU) insider trading activity

Sorrento Therapeutics, Inc. is > 10% Shareholder of Celularity Inc. Currently has a direct ownership of 5.05 Million shares of CELU, which is worth approximately $11.5 Million. The most recent transaction as insider was on Oct 05, 2023, when has been sold 6,307,158 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.05M

0% 3M change

0% 12M change

Total Value Held $11.5 Million

Sorrento Therapeutics, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 05 2023	SELL Open market or private sale	-	6,307,158 Reduced 55.53%	5,050,427 Class A Common Stock
Sep 29 2023	SELL Open market or private sale	-	9,064,539 Reduced 44.39%	11,357,585 Class A Common Stock

Also insider at

VCKA

Vickers Vantage Corp. I Financial Services

> 10% Shareholder

STI